Literature DB >> 7697532

Long-term serologic follow-up of hepatitis C virus-seropositive homosexual men.

O K Ndimbie1, S Nedjar, L Kingsley, P Riddle, C Rinaldo.   

Abstract

Hepatitis C virus (HCV) infection may go undiagnosed and continue to present a source of community-acquired or transfusion-associated infection because of shortcomings in sensitivity, specificity, and reproducibility of serologic tests. This project was designed to longitudinally study persons who were HCV seropositive or were at risk for seroconversion to characterize the course of infection. Sequential serum samples obtained semiannually from 617 homosexual male volunteers were available for study from the Pittsburgh site of the Multicenter AIDS Cohort Study. Testing by anti-HCV enzyme immunoassay (EIA) was performed on baseline (1984 to 1985) and most-recent (censor date, August 1992) samples. Selected samples were also assayed for alanine aminotransferase and by recombinant immunoblot (RIBA II) and nested PCR. A total of 17 of 617 (2.8%) men were HCV seropositive at entry. Of the 600 seronegative men, 9 converted to HCV seropositive during the study interval. Parenteral sources of exposure could be identified in 6 of these 26 HCV-seropositive men. Four men were HCV seropositive at baseline and seronegative at their most recent visit. Of the 26 HCV-seropositive men, 12 were also seropositive for human immunodeficiency virus. EIA analysis of 298 longitudinal samples from the 26 men revealed three patterns of HCV seropositivity: persistent, intermittent, and rare. Nine men (35%) showed intermittent or rare seropositivity with periods of over 1 year between some seropositive samples. PCR was positive in 76% of the HCV EIA-positive and 84% of the RIBA-positive samples. Thus, a low but significant number of homosexual men were HCV seropositive with variable positivity over several years of follow-up. A portion of these men become HCV seronegative. Individuals who exhibit intermittent or rare seropositivity are a challenge to diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697532      PMCID: PMC170131          DOI: 10.1128/cdli.2.2.219-224.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

1.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

Authors:  P Farci; H J Alter; D Wong; R H Miller; J W Shih; B Jett; R H Purcell
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

2.  Hepatitis C virus: evidence for sexual transmission.

Authors:  R S Tedder; R J Gilson; M Briggs; C Loveday; C H Cameron; J A Garson; G E Kelly; I V Weller
Journal:  BMJ       Date:  1991-06-01

3.  Co-amplification of specific sequences of HCV and HIV-1 genomes by using the polymerase chain reaction assay: a potential tool for the simultaneous detection of HCV and HIV-1.

Authors:  S Nedjar; R M Biswas; I K Hewlett
Journal:  J Virol Methods       Date:  1991-12       Impact factor: 2.014

4.  Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.

Authors:  C Rinaldo; L Kingsley; J Neumann; D Reed; P Gupta; D Lyter
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  IgM antibody to hepatitis C virus in acute and chronic hepatitis C.

Authors:  J A Quiroga; M L Campillo; I Catillo; J Bartolomé; J C Porres; V Carreño
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

6.  Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.

Authors:  R D Aach; C E Stevens; F B Hollinger; J W Mosley; D A Peterson; P E Taylor; R G Johnson; L H Barbosa; G J Nemo
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

7.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

8.  IgM antibody response in acute hepatitis C viral infection.

Authors:  J M Clemens; S Taskar; K Chau; D Vallari; J W Shih; H J Alter; J B Schleicher; L T Mimms
Journal:  Blood       Date:  1992-01-01       Impact factor: 22.113

9.  Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins.

Authors:  N Yuki; N Hayashi; A Kasahara; H Hagiwara; K Ohkawa; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

10.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  3 in total

Review 1.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

2.  Fluctuating antibody response in a cohort of hepatitis C patients.

Authors:  Said H S Al Dhahry; Shahina Daar; Jameel C Nograles; Situsekara M W W B Rajapakse; Fadhila S S Al Toqi; Geraldine Z Kaminski
Journal:  J Sci Res Med Sci       Date:  2002-04

Review 3.  An insight into the diagnosis and pathogenesis of hepatitis C virus infection.

Authors:  Mohammad Irshad; Dhananjay Singh Mankotia; Khushboo Irshad
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.